Contact PR

To use this feature, join Babbler easily !

arrow_back

is a free tool for journalists
Do not suffer news anymore, control it


By signing up you will be able to contact hundreds of press officer :
Caroline Grangie
Leboncoin
Media relation manager
Manon Guignard
Uber
Communication Associate
Sheherazade Renoux
PMU
Communication Manager

To learn more, watch the video

You're 1 click away from signing up
What is Babbler!

Previous

Nice to see you again !

Press release

Our focus on improving outcomes for people with diabetes, now and for the future
timer minutes reading time minute reading time

Copy link
Sanofi at EASD | 54th ANNUAL MEETING | Berlin | October 1-5
our-focus-on-improving-outcomes-for-people-with-diabetes-now-and-for-the-future

Click to get original image size

The latest findings from BRIGHT, the first head-to-head randomized controlled trial comparing Toujeo® (insulin glargine 300 Units/mL) with insulin degludec, lead the wealth of medical data Sanofi is contributing to the scientific program at this year’s EASD congress in Berlin.

  • More than 47 Sanofi-related contributions at EASD 2018
  • 14 abstracts relating to Toujeo

  • Health & Medicine
  • Medicine
inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here

  • Health & Medicine
  • Medicine